Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres

OBJECTIVE: To gain an understanding of the efficacy of vedolizumab in a ‘real-world’ setting. DESIGN: Retrospective cohort study using prospectively maintained clinical records. SETTING: Two UK tertiary inflammatory bowel disease (IBD) centres. PATIENTS: Patients with IBD commenced on vedolizumab at...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Frontline Gastroenterol
Κύριοι συγγραφείς: Samaan, Mark A, Pavlidis, Polychronis, Johnston, Emma, Warner, Ben, Digby-Bell, Jonathan, Koumoutsos, Ioannis, Fong, Steven, Goldberg, Rimma, Patel, Kamal, Gulati, Shraddha, Medcalf, Lucy, Sastrillo, Marlene, Brown-Clarke, Cordella, Bidewell-Sullivan, Johanna, Forsyth, Katrina, Lee, Emma, Stanton, Anna, Duncan, Julie, Chung-Faye, Guy, Dubois, Patrick, Powell, Nick, Anderson, Simon, Sanderson, Jeremy, Hayee, Bu'Hussain, Irving, Peter M
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BMJ Publishing Group 2017
Θέματα:
Colorectal
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5558276/
https://ncbi.nlm.nih.gov/pubmed/28839909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2016-100720
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια